Skip to main content
PMC home page
Neuroscience Bulletin logoLink to Neuroscience Bulletin
. 2013 Jul 13;29(4):501–508. doi: 10.1007/s12264-013-1354-7

Protective effects of Batroxobin on spinal cord injury in rats

Hong Fan 11354, Xia Liu 21354, Hai-Bin Tang 31354, Peng Xiao 11354, Ya-Zhou Wang 11354,✉, Gong Ju 11354
PMCID: PMC5561936  PMID: 23852558

Abstract

Expansion of the secondary injury following primary spinal cord injury is a major pathological event that increases destruction in the spinal cord, so measures to reduce secondary injury are needed. Our previous study demonstrated that, at the front of the expanding secondary injury in the spinal cord, there is an ischemic area in which many neurons can still be rescued. Therefore, enhancement of blood circulation in the cord may be helpful, and indeed, we found that a traditional Chinese medicine, shu-xue-tong, efficiently reduces the secondary injury. The aim of the present study was to investigate the effect of reducing fibrinogen with Batroxobin, a drug widely used clinically for ischemia, in rats with spinal cord contusion. We found that both 2 and 4 Batroxobin units (BU)/kg efficiently decreased the plasma fibrinogen, and 2 BU/kg significantly increased spinal blood flow, enhanced neuronal survival, mitigated astrocyte and microglia activation, and improved locomotor recovery. However, 4 BU/kg had no effect on the secondary spinal cord injury. These data suggest that Batroxobin has multiple beneficial effects on spinal cord injury, indicating a potential clinical application.

Keywords: spinal cord injury, secondary injury, fibrinogen, Batroxobin

Contributor Information

Ya-Zhou Wang, Email: yazhouw@fmmu.edu.cn.

Gong Ju, Email: jugong@fmmu.edu.cn, Email: jugong@cashq.ac.cn.

References

  • [1].Cao HQ, Dong ED. An update on spinal cord injury research. Neurosci Bull. 2013;29:94–102. doi: 10.1007/s12264-012-1277-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Mautes AE, Weinzierl MR, Donovan F, Noble LJ. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther. 2000;80:673–687. [PubMed] [Google Scholar]
  • [3].Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 2004;4:451–464. doi: 10.1016/j.spinee.2003.07.007. [DOI] [PubMed] [Google Scholar]
  • [4].Martirosyan NL, Feuerstein JS, Theodore N, Cavalcanti DD, Spetzler RF, Preul MC. Blood supply and vascular reactivity of the spinal cord under normal and pathological conditions. J Neurosurg Spine. 2011;15:238–251. doi: 10.3171/2011.4.SPINE10543. [DOI] [PubMed] [Google Scholar]
  • [5].Takigawa T, Yonezawa T, Yoshitaka T, Minaguchi J, Kurosaki M, Tanaka M, et al. Separation of the perivascular basement membrane provides a conduit for inflammatory cells in a mouse spinal cord injury model. J Neurotrauma. 2010;27:739–751. doi: 10.1089/neu.2009.1111. [DOI] [PubMed] [Google Scholar]
  • [6].Norenberg MD, Smith J, Marcillo A. The pathology of human spinal cord injury: defining the problems. J Neurotrauma. 2004;21:429–440. doi: 10.1089/089771504323004575. [DOI] [PubMed] [Google Scholar]
  • [7].Popa C, Popa F, Grigorean VT, Onose G, Sandu AM, Popescu M, et al. Vascular dysfunctions following spinal cord injury. J Med Life. 2010;3:275–285. [PMC free article] [PubMed] [Google Scholar]
  • [8].Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75:15–26. doi: 10.3171/jns.1991.75.1.0015. [DOI] [PubMed] [Google Scholar]
  • [9].Shen XF, Zhao Y, Zhang YK, Jia LY, Ju G. A modified ferric tannate method for visualizing a blood vessel and its usage in the study of spinal cord injury. Spinal Cord. 2009;47:852–856. doi: 10.1038/sc.2009.30. [DOI] [PubMed] [Google Scholar]
  • [10].Johnson SH, Kraimer JM, Graeber GM. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits. Stroke. 1993;24:1547–1553. doi: 10.1161/01.STR.24.10.1547. [DOI] [PubMed] [Google Scholar]
  • [11].Jia LY, Yao AH, Kuang F, Zhang YK, Shen XF, Ju G. Beneficial effect of the traditional chinese drug shu-xuetong on recovery of spinal cord injury in the rat. Evid Based Complement Alternat Med 2011, 2011. [DOI] [PMC free article] [PubMed]
  • [12].Blomback B. Fibrin formation in whole blood. Thromb Res. 2000;99:307–310. doi: 10.1016/S0049-3848(00)00242-5. [DOI] [PubMed] [Google Scholar]
  • [13].Schachtrup C, Ryu JK, Helmrick MJ, Vagena E, Galanakis DK, Degen JL, et al. Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci. 2010;30:5843–5854. doi: 10.1523/JNEUROSCI.0137-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun. 2012;3:1227. doi: 10.1038/ncomms2230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].You WK, Choi WS, Koh YS, Shin HC, Jang Y, Chung KH. Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris. FEBS Lett. 2004;571:67–73. doi: 10.1016/j.febslet.2004.06.060. [DOI] [PubMed] [Google Scholar]
  • [16].Bell WR., Jr. Defibrinogenating enzymes. Drugs. 1997;54(Suppl3):18–30. doi: 10.2165/00003495-199700543-00005. [DOI] [PubMed] [Google Scholar]
  • [17].Gusev EI, Skvortsova VI, Suslina ZA, Avakian GN, Martynov M, Temirbaeva SL, et al. Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study) Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106:31–34. [PubMed] [Google Scholar]
  • [18].Shiraishi T, Kubo T, Matsunaga T. Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies. Acta Otolaryngol. 1991;111:867–871. doi: 10.3109/00016489109138423. [DOI] [PubMed] [Google Scholar]
  • [19].Plemel JR, Duncan G, Chen KW, Shannon C, Park S, Sparling JS, et al. A graded forceps crush spinal cord injury model in mice. J Neurotrauma. 2008;25:350–370. doi: 10.1089/neu.2007.0426. [DOI] [PubMed] [Google Scholar]
  • [20].Scheff SW, Saucier DA, Cain ME. A statistical method for analyzing rating scale data: the BBB locomotor score. J Neurotrauma. 2002;19:1251–1260. doi: 10.1089/08977150260338038. [DOI] [PubMed] [Google Scholar]
  • [21].Zhu H, Feng YP, Young W, You SW, Shen XF, Liu YS, et al. Early neurosurgical intervention of spinal cord contusion: an analysis of 30 cases. Chin Med J (Engl) 2008;121:2473–2478. [PubMed] [Google Scholar]
  • [22].Adams RA, Passino M, Sachs BD, Nuriel T, Akassoglou K. Fibrin mechanisms and functions in nervous system pathology. Mol Interv. 2004;4:163–176. doi: 10.1124/mi.4.3.6. [DOI] [PubMed] [Google Scholar]

Articles from Neuroscience Bulletin are provided here courtesy of Springer

RESOURCES